Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study by Baccarani, Michele, Rosti, Gianantonio, Castagnetti, Fausto, Haznedaroglu, Ibrahim, Porkka, Kimmo, Abruzzese, Elisabetta, Alimena, Giuliana, Ehrencrona, Hans, Hjorth-Hansen, Henrik, Kairisto, Veli, Levato, Luciano, Martinelli, Giovanni, Nagler, Arnon, Lanng Nielsen, Johan, Ozbek, Ugur, Palandri, Francesca, Palmieri, Fausto, Pane, Fabrizio, Rege-Cambrin, Giovanna, Russo, Domenico, Specchia, Giorgina, Testoni, Nicoletta, Weiss-Bjerrum, Ole, Saglio, Giuseppe, Simonsson, Bengt

Get full text

Combination of pegylated IFN-alpha 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia by Simonsson, Bengt, Gedde-Dahl, Tobias, Markevarn, Berit, Remes, Kari, Stentoft, Jesper, Almqvist, Anders, Bjoreman, Mats, Flogegard, Max, Koskenvesa, Perttu, Lindblom, Anders, Malm, Claes, Mustjoki, Satu, Myhr-Eriksson, Kristina, Ohm, Lotta, Rasanen, Anu, Sinisalo, Marjatta, Sjalander, Anders, Stromberg, Ulla, Weiss Bjerrum, Ole, Ehrencrona, Hans, Gruber, Franz, Kairisto, Veli, Olsson, Karin, Sandin, Fredrik, Nagler, Arnon, Lanng Nielsen, Johan, Hjorth-Hansen, Henrik, Porkka, Kimmo

Get full text

Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients by Schöllkopf, Claudia, Kjeldsen, Lars, Bjerrum, Ole Weiss, Mourits-Andersen, Hans Torben, Nielsen, Johan Lanng, Christensen, Bjarne Egelund, Jensen, Bjarne Anker, Pedersen, Bjarne Bach, Taaning, Ellen Birkerod, Klausen, Tobias Wirenfeldt, Birgens, Henrik

Get full text

Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia by Simonsson, Bengt, Gedde-Dahl, Tobias, Markevärn, Berit, Remes, Kari, Stentoft, Jesper, Almqvist, Anders, Björeman, Mats, Flogegård, Max, Koskenvesa, Perttu, Lindblom, Anders, Malm, Claes, Mustjoki, Satu, Myhr-Eriksson, Kristina, Ohm, Lotta, Räsänen, Anu, Sinisalo, Marjatta, Själander, Anders, Strömberg, Ulla, Bjerrum, Ole Weiss, Ehrencrona, Hans, Gruber, Franz, Kairisto, Veli, Olsson, Karin, Sandin, Fredrik, Nagler, Arnon, Nielsen, Johan Lanng, Hjorth-Hansen, Henrik, Porkka, Kimmo

Get full text

Favorable Therapeutic Responses in Newly Diagnosed CML-CP Patients Induced by Dasatinib Are Reflected At the CD34+CD38+ Progenitor Cell but Not At the CD34+CD38− Stem Cell Level: R... by Mustjoki, Satu, Richter, Johan, Barbany, Gisela, Ehrencrona, Hans, Dybedal, Ingunn, Fioretos, Thoas, Gedde-Dahl, Tobias, Gjertsen, Bjorn, Hovland, Randi, Jalkanen, Sari E, Josefsen, Dag, Koskenvesa, Perttu, Lassen, Carin, Latvala, Kirsi, Majeed, Waleed, Malm, Claes, Markevärn, Berit, Mosfegh, Ali, Ohm, Lotta, Olofsson, Tor, Olsson-Strömberg, Ulla, Rapakko, Katrin, Remes, Kari, Stentoft, Jesper, Stenke, Leif, Suominen, Merja, Thunberg, Sara, Bjerrum, Ole Weiss, Simonsson, Bengt, Porkka, Kimmo, Hjorth-Hansen, Henrik

Get full text

The Proportion of Ph+ CD34+CD38neg Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Corr... by Mustjoki, Satu, Richter, Johan, Barbany, Gisela, Dybedal, Ingunn, Fioretos, Thoas, Gedde-Dahl, Tobias, Gjertsen, Bjorn T., Hovland, Randi, Jalkanen, Sari, Josefsen, Dag, Koskenvesa, Perttu, Lassen, Carin, Latvala, Kirsi, Majeed, Waleed, Malm, Claes, Markevärn, Berit, Moshfegh, Ali, Ohm, Lotta, Olofsson, Tor, Olsson-Strömberg, Ulla, Rapakko, Katrin, Remes, Kari, Stentoft, Jesper, Stenke, Leif, Suominen, Merja, Thunberg, Sara, Bjerrum, Ole Weiss, Simonsson, Bengt, Porkka, Kimmo, Hjorth-Hansen, Henrik

Get full text

A Randomized Phase II Study Comparing Imatinib and the Combination of Imatinib and Pegylated Interferon Alpha-2b in Newly Diagnosed Non-High Risk Chronic Myeloid Leukemia (CML) Pat... by Simonsson, Bengt, Gedde-Dahl, Tobias, Markevärn, Berit, Remes, Kari, Stentoft, Jesper, Almqvist, Anders, Björeman, Mats, Flogegård, Max, Hallman, Heikki, Koskenvesa, Perttu, Lindblom, Anders, Malm, Claes, Mustjoki, Satu, Myhr-Eriksson, Kristina, Räsänen, Anu, Sinisalo, Marjatta, Sippola, Risto, Själander, Anders, Strömberg, Ulla, Bjerrum, Ole Weiss, Ehrencrona, Hans, Gruber, Franz, Kairisto, Veli, Olsson, Karin RN, Nagler, Arnon, Nielsen, Johan Lanng, Hjorth-Hansen, Henrik, Porkka, Kimmo, for the Nordic CML Study Group (NCMLSG)

Get full text

Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis by Hasselbalch, Hans Carl, Bjerrum, Ole Weiss, Jensen, Bjarne Anker, Clausen, Nielsaage Tøffner, Hansen, Per Boye, Birgens, Henrik, Therkildsen, Marianne Hamilton, Ralfkiær, Elisabeth

Get full text

The Proportion of Ph+CD34(+)CD38(neg) Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and C... by Mustjoki, Satu, Richter, Johan, Barbany, Gisela, Dybedal, Ingunn, Fioretos, Thoas, Dahl, Tobias Gedde, Gjertsen, Bjorn T., Hovland, Randi, Jalkanen, Sari, Josefsen, Dag, Koskenvesa, Perttu, Lassen, Carin, Latvala, Kirsi, Majeed, Waleed, Malm, Claes, Markevarn, Berit, Moshfegh, Ali, Ohm, Lotta, Olofsson, Tor, Stromberg, Ulla Olsson, Rapakko, Katrin, Remes, Kari, Stentoft, Jesper, Stenke, Leif, Suominen, Merja, Thunberg, Sara, Bjerrum, Ole Weiss, Simonsson, Bengt, Porkka, Kimmo, Hansen, Henrik Hjorth

Get full text